Whitepaper | Scaling Cell and Gene Therapy Manufacturing
Launch Date: Sept. 9, 2026
Scaling Cell and Gene Therapy Manufacturing With Automated Formulation and Fill-Finish
Cellipont Bioservices and Xiogenix collaborated to evaluate the ARES™ X20+ automated fill-and-finish platform across small- and large-scale cell therapy manufacturing workflows.
Complete the form below to receive your copy and explore the findings.
Name
*
First Name
Last Name
Email
*
example@example.com
Company
*
Comments/Questions
Please verify that you are human
*
Submit
Should be Empty: